2025 AANA
Arete Medical Devices receives multiple awards during the premier innovation challenge for Nurse Anesthesiology Innovators
at the 2025 AANA Rm8 Pitch Competition in Nashville, TN.
Our people and society
View All Services
The #1
Arete’s Line of Oral Airway Devices is Revolutionizing the Industry
Oral airway devices for hospitals.
Oral airway devices for surgery centers.
Oral airway devices for EMTs.
The Arete Adjustable Airway
Arete presents the only product on the market that adjusts to the three most common adult oral airway sizes and is equipped with designated ports for monitoring EtCO2, delivering oxygen, and suctioning.
Years Of Experience
Decades of combined experience in business management and medical industry
Patient Tests
Hundreds of positive tests using the Arete Oral Airway on actual patients
Decrease in Flow Rates
Results show a forty to sixty percent decrease in oxygen flow rates
Want to See it for Yourelf?
Does your facility wish to test the Arete Adjustable Airway and discover what all the fuss is about? Simply fill out the following online form and we will send you a free sample. We just ask for your feedback!
for your free sample
Latest
Arete remains at the forefront of oral airway industry with pilot studies at an array of testing sites at hospitals, surgery centers and universities from coast to coast.
Top Ranked
Testimonials
Want to hear what other CRNA’s and anesthesiologists are saying about Arete’s industry disrupting line of oral airway devices? Take a look at recent testimonials below!
More accurate end-tidal CO2 monitoring compared to a nasal cannula.
Virtua Health
Would recommend Arete’s oral airway to other anesthesia providers.
Vantage Surgical Center
WANT ACTUAL FEEBBACK?
Feedback and testimonials from actual test sites across the country
Dozens of hospitals and surgery centers have experienced the Arete Adjustable Airway firsthand. And, the result did not disappoint:
Call to Test the Arete Adjustable Airway
Learn More
Some of the Nation’s Finest Institutions Have Agreed to Join Our
WHAT YOU NEED TO KNOW
The 2010 House of Delegates of the American Society of Anesthesiologists (ASA) amended its Standards for Basic Anesthetic Monitoring to include mandatory exhaled end-tidal carbon dioxide monitoring during both moderate and deep sedation to its existing requirement for endotracheal and laryngeal mask airway general anesthesia.
It became effective as of July 2011 and now reads:
“During regional anesthesia (with no sedation) or local anesthesia (with no sedation), the adequacy of ventilation shall be evaluated by continual observation of qualitative clinical signs. During moderate or deep sedation, the adequacy of ventilation shall be evaluated by continual observation of qualitative clinical signs and monitoring for the presence of exhaled carbon dioxide unless precluded or invalidated by the nature of the patient, procedure, or equipment.”
Rather than supported by the highest level of evidence-based Class A, Level 1 scientific data, this amendment was a consensus document initiated by the ASA Committee on Standards and Practice Parameters, approved by the ASA Board of Directors, and passed by the October 2010 ASA House of Delegates with supposedly little debate. This new standard makes perfect sense for medical anesthesiologists, particularly those who are based in hospitals, because it costs them essentially nothing to obtain this sometimes very valuable information.
Because in most instances ASA physician anesthesiologist members provide moderate and deep sedation in the same operating rooms as they do general anesthesia, they already have the equipment to monitor EtCO2, and they already routinely use nasal cannula O2 for their sedations. All that is really needed for them to meet this mandate is to either exchange their O2 cannulas for those with a CO2 sampling port for connecting to their EtCO2 monitor or to insert an intravenous catheter into a standard O2 cannula and connect it to monitor.
To complicate this far-reaching ASA requirement, the Centers for Medicare and Medicaid Services (CMS) in 2009 and 2010 rewrote their CMS Hospital Conditions of Participation and Interpretive Guidelines that govern anesthesia services. The CMS mandated that all anesthesia services in a hospital be organized by a qualified physician and consistently implemented in every hospital department and area where “anesthesia services” are rendered. However, as opposed to the ASA standards, the CMS definition of “anesthesia services” excludes topical and local anesthesia, minimal sedation, moderate sedation/analgesia (conscious sedation), and labor epidural analgesia. Thus, even though the CMS does not require standardization of any monitoring, including EtCO2, throughout the hospital for moderate sedation, because the ASA standards require anesthesiologists to monitor EtCO2 for all of their moderate sedations, the ASA believes that other less qualified, nonanesthesiologist sedation practitioners need it even more than their members to enhance their margin of safety. Therefore, if an ASA member is the hospital's “physician in charge of anesthesia services,” he or she may have little choice but to require the monitoring of EtCO2 in all hospital areas where moderate sedation is administered if it is required in the hospital's operating rooms.
Meet
With decades of combined experience in the anesthesia, medical device manufacturing and medical sales industries.
CEO
CEO of Arete Medical Devices and founder of Copper Kettle Anesthesia, a staffing company specializing in anesthesia.
COO
COO of Arete Medical Devices and life-long entrepreneur specializing in partnership management and creative strategies.
Chief of Sales
Managing partner of Trinity Healthcare, specializing in GPO coalitions, IDN's & government purchasing
Podcast Appearance on
Please take the time to listen to the episode and join us as we discuss the mission behind Arete, the future of airway management, and the values driving our work. We’re proud to share this moment with the CRNA community.
Development
Top Ranked
